Founder Lodge | Exchange with founders who raised capital, hired employees & got cashflow.

Certified by Founder Lodge

Abingworth

Venture Capital and Private Equity Principals,

United Kingdom - London, UK

INVESTOR

1 Disclosed Funding Rounds $150,000,000
15 Participating Investments

Organizations in London, UK in Venture Capital and Private Equity Principals

Investors in London, UK in Venture Capital and Private Equity Principals

Operating Status
Active
Last Funding Type
Seed
Company Type
For Profit
Website
https://www.abingworth.com/
Contact
Hunter Lookup
Social Links

Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber man

Company	Date	Round	Raised
Scorpion Therapeutics	July, 17 ,2024	Series C	$150,000,000
Glycomine Inc.	April, 17 ,2025	Series C	$115,000,000
Atsena Therapeutics	April, 07 ,2025	Series C	$150,000,000
Pathalys Pharma	February, 07 ,2023	Unknown	$150,000,000
Glycomine Inc.	April, 17 ,2025	Series C	$115,000,000
Ascend Gene & Cell Therapies	May, 10 ,2023	Series A	$132,500,000
Iambic Therapeutics	October, 06 ,2023	Series B	$100,000,000
Antares Therapeutics	June, 11 ,2025	Series A	$117,000,000
Myricx Bio	July, 09 ,2024	Series A	$115,246,800
Addition Therapeutics	December, 18 ,2025	Unknown	$100,000,000
Scorpion Therapeutics	July, 17 ,2024	Series C	$150,000,000
Atsena Therapeutics	April, 07 ,2025	Series C	$150,000,000
Glycomine Inc.	April, 17 ,2025	Series C	$115,000,000
Antares Therapeutics	June, 11 ,2025	Series A	$117,000,000
Addition Therapeutics	December, 18 ,2025	Unknown	$100,000,000